Senior epidemiologist in the Parsonnet Lab, Division of Infectious Diseases and Geographic MedicineDesign, implement, manage a wide variety of research projects focussed primarily on infectious disease as a cause of chronic disease.Co-teach course: Epidemic Intelligence: How to Identify, Investigate and Interrupt Outbreaks of Disease

Provide epidemiologic, biostatistical and study management expertise for studies and trials in the fields of public health, global health, infectious disease and cancer, including design, management, analysis, report and manuscript preparation.

Provided hands-on expertise for the design, implementation and curation of this start-up company’s secure, web-based collaborative research platform to accelerate the process of drug and vaccine development for neglected and rare diseases. Performed landscape analysis, needs assessment and strategic planning for disease-focused foundations as these groups fund and coordinate drug development with both academic researchers and contract research organizations. Created and implemented processes for the company including project management, resource tracking, budget allocation, professional services pricing management. Identified and facilitated regulatory/ethical oversight.

As above.

Clinical trial team leader for the pivotal phase 3 clinical trial of this non-profit pharmaceutical company’s lead product, the aminoglycoside antibiotic paromomycin, as a cure for the parasitic disease visceral leishmaniasis. Responsible for the design and implementation of the trial in Bihar, India and analysis of trial data. Lead clinical development analyst. Responsible for the design of new trials. Epidemiologist for other clinical trials and epidemiologic studies. Responsible for essential epidemiologic design.Public speaker on the company, global health and drug development, as needed per the development team.

Designed, implemented and analyzed multicenter epidemiologic studies and clinical trials of adverse outcomes to cardiac surgery.